Výsledky vyhledávání - "Robert Ej Ryder"

Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD nationwide empagliflozin audit

Autor: Dennis Barnes, Anurita Rohilla, Alex Bickerton, Robert Ej Ryder, Rajeev Raghavan, Abcd Empagliflozin Audit Contributors, Suzanne Phillips, Devesh Sennik, Ian W. Gallen, Alison Evans, Siva Sivappriyan, Jackie Elliott, Thomas Sj Crabtree

Publikováno v: British Journal of Diabetes. 21:62-66

Introduction: Evidence from phase III and the EMPA-REG OUTCOME trials have demonstrated improvements in renal endpoints with empagliflozin use. The EMPA-KIDNEY trial is currently underway and is assessing whether there are benefits of empagliflozin i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f8032bf1aab37d075dc2d017d9a6b27
https://doi.org/10.15277/bjd.2021.288

Zobrazit plný text záznamu

Improvement in Renal Function in Participants in the First UK National Health Service (NHS) EndoBarrier Service for Uncontrolled Diabesity

Autor: Robert EJ Ryder

Publikováno v: Current Research in Diabetes & Obesity Journal. 15

Aims: EndoBarrier, a 60cm proximal intestinal liner, endoscopically implanted for up to one-year, reduces weight and HbA1c. As the risk of progressive chronic kidney disease (CKD) is increased by high BMI, we assessed the impact of EndoBarrier on ren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf13b7b5313c35786d931957a257898b
https://doi.org/10.19080/crdoj.2021.15.555902

Zobrazit plný text záznamu

Reductions in alanine aminotransferase levels with liraglutide treatment are greatest in those with raised baseline levels and are independent of weight loss: real-world outcome data from the ABCD Nationwide Liraglutide Audit

Autor: Thomas SJ Crabtree, Susannah Rowles, Stephanie Tarpey, Adele Kennedy, John Chalmers, Rahul Nayar, Amanda Lee, Ken Darzy, Peter Winocour, John Lindsay, Iskandar Idris, Ken Y Thong, Piya Sen Gupta, Amar Puttanna, Pranav Kumar, Robert EJ Ryder, On Behalf of ABCD Nationwide Audit Contributors

Publikováno v: British Journal of Diabetes. 19:118-123

People with type 2 diabetes mellitus experience an increased prevalence of non-alcoholic fatty liver disease (NAFLD) compared with the general population and often with worse outcomes. As part of the ABCD Liraglutide Nationwide Audit Programme, we ob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86698fc49f7ca34ddca029b8202e527a
https://doi.org/10.15277/bjd.2019.227

Zobrazit plný text záznamu

COVID-19 outcomes in people with diabetes in Wales: a secondary analysis of the ABCD audit

Autor: David M Williams, Jim Davies, Benjamin CT Field, Rajiv Gandhi, Sophie Harris, Kamlesh Khunti, Dinesh Nagi, Parth Narendran, Rustam Rea, Yue Ruan, Robert EJ Ryder, Kinga A Várnai, Sarah H Wild, Emma G Wilmot, Thinzar Min, Julia Platts, Richard Chudleigh, Jeffrey W Stephens, Sam Rice

Background: People with diabetes and coronavirus disease 2019 (COVID-19) have a significantly greater risk of death and/or intensive care unit (ICU) admission. The Association of British Clinical Diabetologists (ABCD) recently audited outcomes for pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be905785a62378bd4858c2b9af1c7558
https://cronfa.swan.ac.uk/Record/cronfa58989

Zobrazit plný text záznamu

EndoBarrier treatment for longstanding type 2 diabetes and obesity: outcomes one year after EndoBarrier in 90 consecutively treated patients

Autor: Robert EJ Ryder, Mahi Yadagiri, Wyn Burbridge, Susan P Irwin, Hardeep Gandhi, Tahira Bashir, Rachael A Allden, Melanie Wyres, Melissa Cull, John P Bleasdale, Edward N Fogden, Mark R Anderson, Piya Sen Gupta

Publikováno v: Practical Diabetes. 39:13

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::336707cd4931ffdec5ff0e30153dbf6b
https://doi.org/10.1002/pdi.2393

Zobrazit plný text záznamu

Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study

Publikováno v: Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 16:102484

To assess the impact of pre-admission renin-angiotensin-aldosterone system inhibitor (RAASi) and statin use on mortality following COVID-19 hospitalization in adults with pre-existing diabetes.Retrospective cohort study of adults with diabetes admitt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ad62915582508a75a6da4644829356b
https://doi.org/10.1016/j.dsx.2022.102484

Zobrazit plný text záznamu

What now on the CANVAS of diabetes medications with cardiovascular protection? Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives?

Autor: Robert EJ Ryder, Ralph A Defronzo

Publikováno v: British Journal of Diabetes. 17:89

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d2d0f7cf5383e51b6756639353dc26c
https://doi.org/10.15277/bjd.2017.036

Zobrazit plný text záznamu

ABCD now on N3: The ABCD nationwide exenatide QW audit

Autor: Robert Ej Ryder

Publikováno v: British Journal of Diabetes. 14:40

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::980a95cede42b1908b2cf670b0e7befb
https://doi.org/10.15277/bjdvd.2014.009

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání